Medicines for Rare Diseases: No Longer Just on the Horizon
OTHER ALBUM APRIL 17
Pioneering Checkpoint Therapy for Cancer Treatment
The Journey Leading to a New Pill for a Rare Disease
Refreshment Break
Windows into Life: Systems for Modeling Living Things
Building an Antibody Innovation Powerhouse
Lunch in the Orchard
Making Sense of US Politics
AI for Genomic Medicine, Drug Development, and Knowledge Navigation
Lunch in the Orchard
OTHER ALBUM APRIL 16
Welcome
Expanding the Druggable Genome with Small Molecules
Sourcing Innovation Across Academia, Biotech, and Pharma
Discovery Stories and Technologies: Single Cells to AI
Refreshment Break
Public Investors Weigh In on The Market and Current Innovation
Every Breath You Take: Oxygen Sensing and Where it Leads Us
The New Weight Loss Drugs and Their Global Impact on Obesity
Decoding a Billion
Lunch
Using Yale Science to Hijack your Liver: Biohaven’s New Approach to Immune-Mediated Diseases
Will R&D Ever Deliver and, if so, Where the Hell is it Going?
CAR-T Cell Therapy in Autoimmune Disease
Development of an Antisense Drug for a Deadly Neurodegenerative Disease
Novel Oncology Approaches
Paying for Innovation
Private Markets and Mergers: Heating Up or Overheated?
Recital and Dinner at King’s College